首页 > 最新文献

Clinical and Investigative Medicine最新文献

英文 中文
Spring 2023: Clinician Investigator Trainee Association of Canada (CITAC). 2023年春季:加拿大临床研究员培训协会(CITAC)。
IF 0.8 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-03-26 DOI: 10.25011/cim.v46i1.39997
Melissa Phuong, Robert Lao, Yujin Suk, Wenxuan Wang, Amelia Yuan

Over the past year, the leadership of the Clinician Investigator Trainee Association of Canada (CITAC), alongside our MD+ trainees, had the opportunity to further develop and implement our strategic plan in response to the evolving medical landscape. We have dedicated our efforts to the progression towards a post-pandemic environment, have taken advantage of the lessons learned during the coronavirus disease 2019 (COVID-19) health crisis and have focused on enhancing in-person career development opportunities for our members.

在过去的一年里,加拿大临床研究员培训协会(CITAC)的领导,以及我们的医学博士+培训生,有机会进一步制定和实施我们的战略计划,以应对不断变化的医疗环境。我们一直致力于向大流行后环境发展,利用2019年冠状病毒病(COVID-19)健康危机期间的经验教训,并专注于为我们的会员增加面对面的职业发展机会。
{"title":"Spring 2023: Clinician Investigator Trainee Association of Canada (CITAC).","authors":"Melissa Phuong,&nbsp;Robert Lao,&nbsp;Yujin Suk,&nbsp;Wenxuan Wang,&nbsp;Amelia Yuan","doi":"10.25011/cim.v46i1.39997","DOIUrl":"https://doi.org/10.25011/cim.v46i1.39997","url":null,"abstract":"<p><p>Over the past year, the leadership of the Clinician Investigator Trainee Association of Canada (CITAC), alongside our MD+ trainees, had the opportunity to further develop and implement our strategic plan in response to the evolving medical landscape. We have dedicated our efforts to the progression towards a post-pandemic environment, have taken advantage of the lessons learned during the coronavirus disease 2019 (COVID-19) health crisis and have focused on enhancing in-person career development opportunities for our members.</p>","PeriodicalId":50683,"journal":{"name":"Clinical and Investigative Medicine","volume":"46 1","pages":"E1-3"},"PeriodicalIF":0.8,"publicationDate":"2023-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9804298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ribavirin Does Not Enhance Hepatitis B Virus Nucleotide Antiviral Activity: A Pilot Study. 利巴韦林不能增强乙型肝炎病毒核苷酸抗病毒活性:一项初步研究。
IF 0.8 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2022-12-31 DOI: 10.25011/cim.v45i4.39274
Alexa Keeshan, Carla Coffin, Alicia Vachon, Nishi Patel, Scott Fung, Leanne Mortimer, Angela Crawley, Mang Ma, Carla Osiowy, Curtis Cooper

Purpose: There is a need for effective and affordable treatments that achieve hepatitis B virus (HBV) functional cure and prevent long-term complications. The use of immune-modulators combined with HBV antivirals is a promising therapeutic strategy to achieve these goals. Based on ribavirin (RBV) monotherapy data, we hypothesized that RBV could improve virological responses when used in combination with tenofovir.  Methods: In this randomized, open label, controlled pilot trial, we evaluated RBV (n=4) dosed for the initial 24 weeks of treatment versus no RBV (n=4) in tenofovir recipients dosed over 48 weeks.  Results: Although well tolerated and safe in combination with tenofovir, RBV demonstrated no beneficial effects on virologic, biochemical or immunological markers of chronic HBV infection over 48 weeks of serial evaluation.  Conclusions: Our data does not suggest a HBV-specific immunomodulatory effect or an impact of RBV on HBV virological and antigen suppression.

目的:需要有效和负担得起的治疗方法,以实现乙型肝炎病毒(HBV)功能性治愈并预防长期并发症。使用免疫调节剂联合HBV抗病毒药物是实现这些目标的一种有希望的治疗策略。基于利巴韦林(RBV)单药治疗数据,我们假设RBV与替诺福韦联合使用可以改善病毒学反应。方法:在这项随机、开放标签、对照的试点试验中,我们评估了替诺福韦治疗最初24周时服用RBV (n=4)与48周后服用无RBV (n=4)的替诺福韦受体。结果:尽管RBV与替诺福韦联合使用耐受性良好且安全,但在48周的系列评估中,RBV对慢性HBV感染的病毒学、生化或免疫学标志物没有有益的影响。结论:我们的数据不表明HBV特异性免疫调节作用或RBV对HBV病毒学和抗原抑制的影响。
{"title":"Ribavirin Does Not Enhance Hepatitis B Virus Nucleotide Antiviral Activity: A Pilot Study.","authors":"Alexa Keeshan,&nbsp;Carla Coffin,&nbsp;Alicia Vachon,&nbsp;Nishi Patel,&nbsp;Scott Fung,&nbsp;Leanne Mortimer,&nbsp;Angela Crawley,&nbsp;Mang Ma,&nbsp;Carla Osiowy,&nbsp;Curtis Cooper","doi":"10.25011/cim.v45i4.39274","DOIUrl":"https://doi.org/10.25011/cim.v45i4.39274","url":null,"abstract":"<p><strong>Purpose: </strong>There is a need for effective and affordable treatments that achieve hepatitis B virus (HBV) functional cure and prevent long-term complications. The use of immune-modulators combined with HBV antivirals is a promising therapeutic strategy to achieve these goals. Based on ribavirin (RBV) monotherapy data, we hypothesized that RBV could improve virological responses when used in combination with tenofovir.  Methods: In this randomized, open label, controlled pilot trial, we evaluated RBV (n=4) dosed for the initial 24 weeks of treatment versus no RBV (n=4) in tenofovir recipients dosed over 48 weeks.  Results: Although well tolerated and safe in combination with tenofovir, RBV demonstrated no beneficial effects on virologic, biochemical or immunological markers of chronic HBV infection over 48 weeks of serial evaluation.  Conclusions: Our data does not suggest a HBV-specific immunomodulatory effect or an impact of RBV on HBV virological and antigen suppression.</p>","PeriodicalId":50683,"journal":{"name":"Clinical and Investigative Medicine","volume":"45 4","pages":"E11-15"},"PeriodicalIF":0.8,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10609676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hats Off to the CIM Reviewers Of 2022. 向2022年CIM评审员致敬。
IF 0.8 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2022-12-31 DOI: 10.25011/cim.v45i4.39559
Robert Bortolussi

For over 40 years the journal of Clinical and Investigative Medicine (CIM) has published articles of interest to clinician investigators in Canada and elsewhere. We strive for the highest standards and to remain relevant to our readers, but we cannot achieve this goal without the help of our reviewers, all of whom play a vital role in maintaining the integrity of the scientific process. Without their efforts, academic excellence would falter.

40多年来,临床和调查医学杂志(CIM)发表了加拿大和其他地方临床研究人员感兴趣的文章。我们力求达到最高标准,并与读者保持联系,但如果没有审稿人的帮助,我们就无法实现这一目标,他们在维护科学过程的完整性方面都发挥着至关重要的作用。没有他们的努力,优秀的学术成就就会动摇。
{"title":"Hats Off to the CIM Reviewers Of 2022.","authors":"Robert Bortolussi","doi":"10.25011/cim.v45i4.39559","DOIUrl":"https://doi.org/10.25011/cim.v45i4.39559","url":null,"abstract":"<p><p>For over 40 years the journal of Clinical and Investigative Medicine (CIM) has published articles of interest to clinician investigators in Canada and elsewhere. We strive for the highest standards and to remain relevant to our readers, but we cannot achieve this goal without the help of our reviewers, all of whom play a vital role in maintaining the integrity of the scientific process. Without their efforts, academic excellence would falter.</p>","PeriodicalId":50683,"journal":{"name":"Clinical and Investigative Medicine","volume":"45 4","pages":"E90"},"PeriodicalIF":0.8,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10832433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022 Joint Meeting On Transplantation: Canadian Society of Transplantation And Banff Foundation of Allograft Pathology. 2022年移植联合会议:加拿大移植学会和班夫同种异体移植病理基金会。
IF 0.8 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2022-12-31 DOI: 10.25011/cim.v45i4.39557
Jeffry Schiff, Michael Mengel

The Canadian Society of Transplantation (CST) annual scientific meeting was held in Banff Alberta September 19-23, 2022. It provided a forum for the transplantation community to share ideas, leading practices, innovative science and educational content in transplant care. The meeting brought together members of the Banff Foundation for Allograft Pathology and the CST for a hybrid event, combining both in-person and virtual experiences, and helping the two societies reach a wider audience. With over 600 Canadian and International delegates attending, the 2022 Banff-CST Meeting received outstanding educational programming, but also rare opportunities to connect with transplantation professionals from all over the world.

加拿大移植学会(CST)年度科学会议于2022年9月19日至23日在阿尔伯塔省班夫举行。它为移植界提供了一个论坛,分享移植护理方面的想法、领先实践、创新科学和教育内容。这次会议将班夫同种异体病理学基金会和CST的成员聚集在一起,进行了一次混合活动,结合了面对面和虚拟的体验,并帮助两个协会接触到更广泛的受众。超过600名加拿大和国际代表参加了2022年班夫- cst会议,不仅获得了出色的教育计划,而且还获得了与来自世界各地的移植专业人士交流的难得机会。
{"title":"2022 Joint Meeting On Transplantation: Canadian Society of Transplantation And Banff Foundation of Allograft Pathology.","authors":"Jeffry Schiff,&nbsp;Michael Mengel","doi":"10.25011/cim.v45i4.39557","DOIUrl":"https://doi.org/10.25011/cim.v45i4.39557","url":null,"abstract":"<p><p>The Canadian Society of Transplantation (CST) annual scientific meeting was held in Banff Alberta September 19-23, 2022. It provided a forum for the transplantation community to share ideas, leading practices, innovative science and educational content in transplant care. The meeting brought together members of the Banff Foundation for Allograft Pathology and the CST for a hybrid event, combining both in-person and virtual experiences, and helping the two societies reach a wider audience. With over 600 Canadian and International delegates attending, the 2022 Banff-CST Meeting received outstanding educational programming, but also rare opportunities to connect with transplantation professionals from all over the world.</p>","PeriodicalId":50683,"journal":{"name":"Clinical and Investigative Medicine","volume":"45 4","pages":"E46-89"},"PeriodicalIF":0.8,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10609674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Elevated Serum Interleukin-17 Levels in Thoracic Trauma Patients with Poor Prognosis: A Prospective Observational Study. 预后不良的胸外伤患者血清白细胞介素-17水平升高:一项前瞻性观察研究
IF 0.8 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2022-12-31 DOI: 10.25011/cim.v45i4.39558
Qiang Wang, Xiaoliu Li, Jing Zhang, Lian Xiang, Jing Dong

Purpose: To measure interleukin (IL)-17 serum levels in thoracic trauma patients and to correlate these levels with other cytokines and with patient prognosis.  Methods: This prospective observational study recruited 130 thoracic trauma patients who were admitted to the Zhoupu Hospital Affiliated to Shanghai Medical College of Health June 2020 to April 2022 and 100 healthy volunteers. Patients were divided into two groups based on Injury Severity Score (ISS): ISS<16 (mild/moderate trauma) and ISS ≥16 (severe trauma). Serum IL-17, tumor necrosis factor α (TNF-α), IL-6, IL-1β and C-reactive protein (CRP) levels were measured by enzyme-linked immunosorbent assay. Patients with poor prognosis were defined as those who developed serious complications or died during hospitalization or follow-up.  Results: Serum levels of IL-17, TNF-α, IL-6 and IL-1β were significantly elevated in patients with ISS ≥16 (p<0.05). Serum cytokines levels increased within 48 h in both groups and then gradually decreased during subsequent treatment and rehabilitation. Pearson's analysis indicated a positive correlation among IL-17, TNF-α and IL-1β. Serum IL-17 levels in patients with poor prognoses were higher than the patients with good prognoses at all time points (p<0.05). Furthermore, for patients with poor prognoses, the serum IL-17 levels had highest diagnostic value among all the cytokines measured. Logistic regression analysis showed that IL-17 was the risk factor for thoracic trauma patients with poor prognoses.  Conclusion: Serum IL-17 levels were significantly elevated in thoracic trauma patients and decreased gradually with rehabilitation. IL-17 was a risk factor for thoracic trauma patients with poor prognoses. This study suggests a new diagnostic and therapeutic target for thoracic trauma patients.

目的:测定胸外伤患者血清白细胞介素(IL)-17水平,并探讨其与其他细胞因子及预后的关系。方法:本前瞻性观察研究招募了2020年6月至2022年4月上海卫生学院附属周浦医院收治的130例胸部外伤患者和100名健康志愿者。根据损伤严重程度评分(ISS)将患者分为两组:ISS
{"title":"Elevated Serum Interleukin-17 Levels in Thoracic Trauma Patients with Poor Prognosis: A Prospective Observational Study.","authors":"Qiang Wang,&nbsp;Xiaoliu Li,&nbsp;Jing Zhang,&nbsp;Lian Xiang,&nbsp;Jing Dong","doi":"10.25011/cim.v45i4.39558","DOIUrl":"https://doi.org/10.25011/cim.v45i4.39558","url":null,"abstract":"<p><strong>Purpose: </strong>To measure interleukin (IL)-17 serum levels in thoracic trauma patients and to correlate these levels with other cytokines and with patient prognosis.  Methods: This prospective observational study recruited 130 thoracic trauma patients who were admitted to the Zhoupu Hospital Affiliated to Shanghai Medical College of Health June 2020 to April 2022 and 100 healthy volunteers. Patients were divided into two groups based on Injury Severity Score (ISS): ISS<16 (mild/moderate trauma) and ISS ≥16 (severe trauma). Serum IL-17, tumor necrosis factor α (TNF-α), IL-6, IL-1β and C-reactive protein (CRP) levels were measured by enzyme-linked immunosorbent assay. Patients with poor prognosis were defined as those who developed serious complications or died during hospitalization or follow-up.  Results: Serum levels of IL-17, TNF-α, IL-6 and IL-1β were significantly elevated in patients with ISS ≥16 (p<0.05). Serum cytokines levels increased within 48 h in both groups and then gradually decreased during subsequent treatment and rehabilitation. Pearson's analysis indicated a positive correlation among IL-17, TNF-α and IL-1β. Serum IL-17 levels in patients with poor prognoses were higher than the patients with good prognoses at all time points (p<0.05). Furthermore, for patients with poor prognoses, the serum IL-17 levels had highest diagnostic value among all the cytokines measured. Logistic regression analysis showed that IL-17 was the risk factor for thoracic trauma patients with poor prognoses.  Conclusion: Serum IL-17 levels were significantly elevated in thoracic trauma patients and decreased gradually with rehabilitation. IL-17 was a risk factor for thoracic trauma patients with poor prognoses. This study suggests a new diagnostic and therapeutic target for thoracic trauma patients.</p>","PeriodicalId":50683,"journal":{"name":"Clinical and Investigative Medicine","volume":"45 4","pages":"E39-45"},"PeriodicalIF":0.8,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10609675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
University of Montreal's Clinician-Investigator Program: A 10-Year Descriptive Evaluation. 蒙特利尔大学临床医师-研究者项目:10年描述性评价。
IF 0.8 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2022-12-31 DOI: 10.25011/cim.v45i4.39275
Samuel Mailhot-Larouche, Vincent Chauvette, David Bergeron, Catherine Larochelle, Geneviève Du Pont-Thibodeau, Han Wang, Héloïse Cardinal, Isabelle Bourdeau, Nathalie Auger, Nathalie Bureau Md MSc Bureau, Alexandre Prat, Didier Jutras-Aswad, François Madore, Guillaume Emeriaud, Houda Bahig, Marie-Hélène Mayrand, Rafik Tadros, Stefan Parent, Philippe Richebe Md PhD Richebe, Yahye Merhi, Dang Nguyen

Purpose: Clinician-investigators have an important role in the development and implantation of new therapies and treatment modalities; however, there have been several reports highlighting a pending shortage in the clinician-investigators' workforce. In Canada, the Royal College has promoted the development of clinician-investigators programs (CIP) to facilitate the training of these individuals. There is currently a paucity of data regarding the outcomes of such programs. This study aims to identify the strengths and areas of improvement of the Montreal University CIP.  Methods: An internet-based 51-question survey was distributed to all the alumni from the University of Montreal CIP. Participation was voluntary and no incentives were provided. The response rate was 64%.  Results: Among respondents, 50% (n=16) had completed their clinical residency and all CIP requirements. The majority of these individuals (63%) had become independent investigators and had secured provincial and national funding. Satisfaction of the respondents was high regarding the overall program (85%), the research skills developed during the CIP (84%) and the financial support obtained during the program (72%). The satisfaction rate regarding career planning was lower (63%).  Conclusion: This survey demonstrates that, while indicators are favorable, some areas still require improvement. Several steps to improve the CIP have been identified; notably, the transition from the CIP to early independent career has been identified as critical in the development of clinician-investigators and steps have been taken to improve this progression.

目的:临床研究者在新疗法和治疗方式的开发和实施中发挥着重要作用;然而,有几份报告强调了临床研究人员的劳动力短缺。在加拿大,皇家学院促进了临床研究人员计划(CIP)的发展,以促进这些个人的培训。目前缺乏关于这些项目结果的数据。本研究旨在确定蒙特利尔大学CIP的优势和改进领域。方法:采用网络调查的方式,对蒙特利尔大学CIP的所有校友进行问卷调查。参与是自愿的,不提供奖励。应答率为64%。结果:在受访者中,50% (n=16)完成了临床住院治疗和所有CIP要求。这些人中的大多数(63%)已成为独立调查员,并获得了省和国家的资助。受访者对整个计划(85%),在CIP期间发展的研究技能(84%)和在计划期间获得的经济支持(72%)的满意度很高。职业规划满意度较低(63%)。结论:本次调查显示,虽然各项指标较好,但仍有一些领域有待改进。已经确定了改善CIP的几个步骤;值得注意的是,从CIP到早期独立职业的过渡已经被确定为临床研究人员发展的关键,并且已经采取措施来改善这一进展。
{"title":"University of Montreal's Clinician-Investigator Program: A 10-Year Descriptive Evaluation.","authors":"Samuel Mailhot-Larouche,&nbsp;Vincent Chauvette,&nbsp;David Bergeron,&nbsp;Catherine Larochelle,&nbsp;Geneviève Du Pont-Thibodeau,&nbsp;Han Wang,&nbsp;Héloïse Cardinal,&nbsp;Isabelle Bourdeau,&nbsp;Nathalie Auger,&nbsp;Nathalie Bureau Md MSc Bureau,&nbsp;Alexandre Prat,&nbsp;Didier Jutras-Aswad,&nbsp;François Madore,&nbsp;Guillaume Emeriaud,&nbsp;Houda Bahig,&nbsp;Marie-Hélène Mayrand,&nbsp;Rafik Tadros,&nbsp;Stefan Parent,&nbsp;Philippe Richebe Md PhD Richebe,&nbsp;Yahye Merhi,&nbsp;Dang Nguyen","doi":"10.25011/cim.v45i4.39275","DOIUrl":"https://doi.org/10.25011/cim.v45i4.39275","url":null,"abstract":"<p><strong>Purpose: </strong>Clinician-investigators have an important role in the development and implantation of new therapies and treatment modalities; however, there have been several reports highlighting a pending shortage in the clinician-investigators' workforce. In Canada, the Royal College has promoted the development of clinician-investigators programs (CIP) to facilitate the training of these individuals. There is currently a paucity of data regarding the outcomes of such programs. This study aims to identify the strengths and areas of improvement of the Montreal University CIP.  Methods: An internet-based 51-question survey was distributed to all the alumni from the University of Montreal CIP. Participation was voluntary and no incentives were provided. The response rate was 64%.  Results: Among respondents, 50% (n=16) had completed their clinical residency and all CIP requirements. The majority of these individuals (63%) had become independent investigators and had secured provincial and national funding. Satisfaction of the respondents was high regarding the overall program (85%), the research skills developed during the CIP (84%) and the financial support obtained during the program (72%). The satisfaction rate regarding career planning was lower (63%).  Conclusion: This survey demonstrates that, while indicators are favorable, some areas still require improvement. Several steps to improve the CIP have been identified; notably, the transition from the CIP to early independent career has been identified as critical in the development of clinician-investigators and steps have been taken to improve this progression.</p>","PeriodicalId":50683,"journal":{"name":"Clinical and Investigative Medicine","volume":"45 4","pages":"E1-10"},"PeriodicalIF":0.8,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10602833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Value Of Anteroposterior-To-Transverse Ratio in Ultrasonic Diagnosis of Thyroid Nodule in Different Locations. 超声正横比对不同部位甲状腺结节的诊断价值。
IF 0.8 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2022-12-31 DOI: 10.25011/cim.v45i4.38877
Hai-Ning Zheng, Wei Wang Md Wang, Xiao-Qing Wang Md Wang, Wen-Jing Song, Wen-Jing Song, Rui Zhao, Meng Li, Chao-Yang Wen Md Wen

Purpose: To investigate the value of anteroposterior-to-transverse ratio (ATR) and the effect on features of nodules in ultrasound (US) diagnosis of thyroid nodules in different locations.  Methods: The nodules were divided into three groups according to the different nodule location: isthmus group; upper and lower poles of bilobed thyroid group; and the middle of the bilobed thyroid group. The diameters of the nodules were recorded, and ATR of the nodule was calculated on the transverse and longitudinal sections. The transverse and the longitudinal sections of ATR of thyroid nodules in different groups were compared.  Result: The transverse section of ATR was significantly different among the three groups (p = 0.001). In addition, there are significant differences in many US features among three groups, including nodule composition, thyroid parenchyma, morphology, echogenicity, shape, calcifications, vascularity, nodule ACR TI-RADS and histopathologic (all p < 0.05). In the group of upper and lower poles of bilobed thyroid, significant difference was found between the transverse and the longitudinal section of ATR (p = 0.019). The cut-off values of transverse section and longitudinal section of ATR were 0.967 and 0.750, respectively.  Conclusion: The transverse section of ATR at different location of thyroid may be a predictor for malignancy with clinical diagnostic significance.

目的:探讨正横比(ATR)在不同部位甲状腺结节超声诊断中的价值及对结节特征的影响。方法:根据结节位置的不同将结节分为三组:峡部组;双叶状甲状腺群上、下两极;还有中间的双叶状甲状腺。记录结节直径,在横切面和纵切面计算结节的ATR。比较不同组甲状腺结节的ATR横切面和纵切面。结果:三组间ATR横切面差异有统计学意义(p = 0.001)。此外,三组在结节组成、甲状腺实质、形态学、回声性、形状、钙化、血管、结节ACR、TI-RADS、组织病理学等诸多US特征上均存在显著差异(p < 0.05)。在双叶甲状腺上、下两极组,ATR横切面与纵切面差异有统计学意义(p = 0.019)。ATR横切面和纵切面的截止值分别为0.967和0.750。结论:甲状腺不同部位ATR横切面可作为恶性肿瘤的预测指标,具有临床诊断意义。
{"title":"Value Of Anteroposterior-To-Transverse Ratio in Ultrasonic Diagnosis of Thyroid Nodule in Different Locations.","authors":"Hai-Ning Zheng,&nbsp;Wei Wang Md Wang,&nbsp;Xiao-Qing Wang Md Wang,&nbsp;Wen-Jing Song,&nbsp;Wen-Jing Song,&nbsp;Rui Zhao,&nbsp;Meng Li,&nbsp;Chao-Yang Wen Md Wen","doi":"10.25011/cim.v45i4.38877","DOIUrl":"https://doi.org/10.25011/cim.v45i4.38877","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the value of anteroposterior-to-transverse ratio (ATR) and the effect on features of nodules in ultrasound (US) diagnosis of thyroid nodules in different locations.  Methods: The nodules were divided into three groups according to the different nodule location: isthmus group; upper and lower poles of bilobed thyroid group; and the middle of the bilobed thyroid group. The diameters of the nodules were recorded, and ATR of the nodule was calculated on the transverse and longitudinal sections. The transverse and the longitudinal sections of ATR of thyroid nodules in different groups were compared.  Result: The transverse section of ATR was significantly different among the three groups (p = 0.001). In addition, there are significant differences in many US features among three groups, including nodule composition, thyroid parenchyma, morphology, echogenicity, shape, calcifications, vascularity, nodule ACR TI-RADS and histopathologic (all p < 0.05). In the group of upper and lower poles of bilobed thyroid, significant difference was found between the transverse and the longitudinal section of ATR (p = 0.019). The cut-off values of transverse section and longitudinal section of ATR were 0.967 and 0.750, respectively.  Conclusion: The transverse section of ATR at different location of thyroid may be a predictor for malignancy with clinical diagnostic significance.</p>","PeriodicalId":50683,"journal":{"name":"Clinical and Investigative Medicine","volume":"45 4","pages":"E25-32"},"PeriodicalIF":0.8,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10609678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis Of The Association Between Sh2B1 chr16.28884655 And Type 2 Diabetes. Sh2B1 chr16.28884655与2型糖尿病的相关性分析
IF 0.8 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2022-12-31 DOI: 10.25011/cim.v45i4.39273
Jingjin Liu, Renjun Cao, Dewei Li, Fang Miao, Ping An Yang, Hui He, Han Yu, Xiang Zhang, Jie Qin, Yanlan Yang

Purpose: To determine correlation between genetic susceptibility of type 2 diabetes mellitus (T2DM) and Src homology 2 B adapter protein 1 (SH2B1) gene polymorphism in a diabetic population.  Methods: A total of 111 T2DM patients (DM group) and 34 healthy controls (NC group) from Shanxi Provincial People's Hospital were included in this study. Exon 9 of the SH2B1 gene was detected using the Sanger sequencing method, and the relationship between SH2B1 gene polymorphism and diabetes was analyzed.  Results: Comparison of the data between the two groups showed that the values of TG, the updated HOMA of insulin resistance (HOMA2-IR), weight, body mass index, waist circumference, fasting blood glucose and fasting insulin levels of the DM group were higher than those of the NC group (P < 0.05). The HOMA2 insulin sensitivity (%S) of the DM group was lower than that of the NC group (P < 0.05). Sequencing analysis revealed that the following five single nucleotide polymorphisms in exon 9 of SH2B1 may be related to T2DM: rs181578610, rs550079240, chr16.28884655, chr16.28884659 and chr16.28884831. Among them, chr16.28884655 was found to be significantly related to diabetes; this site, located on the NM_015503 exon, was related to TG, LDL-C and waist circumference.

Conclusion: The SH2B1 gene locus chr16.28884655 was found to be significantly related to genetic susceptibility to T2DM.

目的:探讨糖尿病人群中2型糖尿病(T2DM)遗传易感性与Src同源性2b适配蛋白1 (SH2B1)基因多态性的相关性。方法:选取山西省人民医院T2DM患者111例(DM组)和健康对照34例(NC组)进行研究。采用Sanger测序法检测SH2B1基因外显子9,分析SH2B1基因多态性与糖尿病的关系。结果:两组数据比较,DM组TG、胰岛素抵抗更新HOMA (HOMA2-IR)、体重、体质指数、腰围、空腹血糖、空腹胰岛素水平均高于NC组(P < 0.05)。DM组HOMA2胰岛素敏感性(%S)低于NC组(P < 0.05)。测序分析显示,SH2B1基因第9外显子的5个单核苷酸多态性可能与T2DM相关:rs181578610、rs550079240、chr16.28884655、chr16.28884659和chr16.28884831。其中,发现chr16.28884655与糖尿病显著相关;该位点位于NM_015503外显子,与TG、LDL-C和腰围有关。结论:发现SH2B1基因位点chr16.28884655与T2DM遗传易感性显著相关。
{"title":"Analysis Of The Association Between Sh2B1 chr16.28884655 And Type 2 Diabetes.","authors":"Jingjin Liu,&nbsp;Renjun Cao,&nbsp;Dewei Li,&nbsp;Fang Miao,&nbsp;Ping An Yang,&nbsp;Hui He,&nbsp;Han Yu,&nbsp;Xiang Zhang,&nbsp;Jie Qin,&nbsp;Yanlan Yang","doi":"10.25011/cim.v45i4.39273","DOIUrl":"https://doi.org/10.25011/cim.v45i4.39273","url":null,"abstract":"<p><strong>Purpose: </strong>To determine correlation between genetic susceptibility of type 2 diabetes mellitus (T2DM) and Src homology 2 B adapter protein 1 (SH2B1) gene polymorphism in a diabetic population.  Methods: A total of 111 T2DM patients (DM group) and 34 healthy controls (NC group) from Shanxi Provincial People's Hospital were included in this study. Exon 9 of the SH2B1 gene was detected using the Sanger sequencing method, and the relationship between SH2B1 gene polymorphism and diabetes was analyzed.  Results: Comparison of the data between the two groups showed that the values of TG, the updated HOMA of insulin resistance (HOMA2-IR), weight, body mass index, waist circumference, fasting blood glucose and fasting insulin levels of the DM group were higher than those of the NC group (P < 0.05). The HOMA2 insulin sensitivity (%S) of the DM group was lower than that of the NC group (P < 0.05). Sequencing analysis revealed that the following five single nucleotide polymorphisms in exon 9 of SH2B1 may be related to T2DM: rs181578610, rs550079240, chr16.28884655, chr16.28884659 and chr16.28884831. Among them, chr16.28884655 was found to be significantly related to diabetes; this site, located on the NM_015503 exon, was related to TG, LDL-C and waist circumference.</p><p><strong>Conclusion: </strong>The SH2B1 gene locus chr16.28884655 was found to be significantly related to genetic susceptibility to T2DM.</p>","PeriodicalId":50683,"journal":{"name":"Clinical and Investigative Medicine","volume":"45 4","pages":"E33-38"},"PeriodicalIF":0.8,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10609673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changes in Vector Astigmatism After Superotemporal Versus Temporal Clear Corneal Incision Cataract Surgery. 颞上角膜切口白内障手术与颞上角膜切口白内障手术后矢量散光的变化。
IF 0.8 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2022-12-31 DOI: 10.25011/cim.v45i4.38934
Zhennan Zhao, Qi Fan, Yongxiang Jiang, Yi Lu

Purpose: To investigate vector and refractive astigmatism changes after superotemporal versus temporal clear corneal incision cataract surgery.

Methods: Patients were diagnosed with age-related cataract with corneal astigmatism < 1.5 diopters (D) and were divided into two groups: superotemporal incision (R group) and temporal incision (L group). Uncorrected visual acuity, manifest refraction, corneal topography, anterior segment optical coherence tomography was performed pre- and six months postoperatively. Total ocular astigmatism, corneal astigmatism, vector of surgically induced corneal astigmatism (SICA), non-corneal ocular residual astigmatism (N-CORA), postoperative intraocular lens decentration and tilt were analyzed.  Results: Thirty-eight subjects were included: 21, R group; 17, L group. After surgery, the N-CORA decreased significantly from 1.17±0.72 D to 0.73±0.47 D in all patients (P=0.001), 1.03±0.52 D to 0.70±0.40 D in the R group (P=0.005) and 1.35±0.90 D to 0.78±0.55 D in the L group (P=0.033). Significant differences between t:he R and L groups were found in the postoperative meridian of anterior corneal astigmatism (75.95±52.50 vs 116.79±47.29; P=0.017), total corneal astigmatism (51.65±42.75 vs 95.20±57.32; P=0.011), J45 change vector of SICA in the anterior cornea (-0.10±0.18 vs 0.00±0.11; P=0.048) and total cornea surface (-0.14±0.17 vs 0.03±0.12; P=0.001).  Conclusion: The N-CORA decreased significantly after cataract surgery. Superotemporal and temporal incisions caused differences in the meridian components of oblique astigmatism in some patients but did not have a significant effect on the magnitude of corneal astigmatism.

目的:探讨颞上角膜切口白内障手术与颞上角膜切口白内障手术后角膜矢量散光和屈光散光的变化。方法:将诊断为年龄相关性白内障且角膜散光< 1.5屈光度(D)的患者分为颞上切口组(R组)和颞下切口组(L组)。术前和术后6个月分别行未矫正视力、明显屈光、角膜地形图、前段光学相干断层扫描。分析全眼散光、角膜散光、术源性角膜散光载体(SICA)、非角膜残留散光载体(N-CORA)、术后人工晶状体脱位和倾斜情况。结果:共纳入38例受试者:R组21例;17, L族。术后所有患者N-CORA均由1.17±0.72 D降至0.73±0.47 D (P=0.001), R组为1.03±0.52 D降至0.70±0.40 D (P=0.005), L组为1.35±0.90 D降至0.78±0.55 D (P=0.033)。R组与L组术后角膜前散光经络差异有统计学意义(75.95±52.50 vs 116.79±47.29);P=0.017),角膜总散光(51.65±42.75 vs 95.20±57.32;P=0.011),前角膜SICA的J45变化矢量(-0.10±0.18 vs 0.00±0.11;P=0.048)和角膜总表面积(-0.14±0.17 vs 0.03±0.12;P = 0.001)。结论:白内障术后N-CORA明显下降。颞上切口和颞上切口导致部分患者斜向散光的经络成分存在差异,但对角膜散光的大小没有显著影响。
{"title":"Changes in Vector Astigmatism After Superotemporal Versus Temporal Clear Corneal Incision Cataract Surgery.","authors":"Zhennan Zhao,&nbsp;Qi Fan,&nbsp;Yongxiang Jiang,&nbsp;Yi Lu","doi":"10.25011/cim.v45i4.38934","DOIUrl":"https://doi.org/10.25011/cim.v45i4.38934","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate vector and refractive astigmatism changes after superotemporal versus temporal clear corneal incision cataract surgery.</p><p><strong>Methods: </strong>Patients were diagnosed with age-related cataract with corneal astigmatism < 1.5 diopters (D) and were divided into two groups: superotemporal incision (R group) and temporal incision (L group). Uncorrected visual acuity, manifest refraction, corneal topography, anterior segment optical coherence tomography was performed pre- and six months postoperatively. Total ocular astigmatism, corneal astigmatism, vector of surgically induced corneal astigmatism (SICA), non-corneal ocular residual astigmatism (N-CORA), postoperative intraocular lens decentration and tilt were analyzed.  Results: Thirty-eight subjects were included: 21, R group; 17, L group. After surgery, the N-CORA decreased significantly from 1.17±0.72 D to 0.73±0.47 D in all patients (P=0.001), 1.03±0.52 D to 0.70±0.40 D in the R group (P=0.005) and 1.35±0.90 D to 0.78±0.55 D in the L group (P=0.033). Significant differences between t:he R and L groups were found in the postoperative meridian of anterior corneal astigmatism (75.95±52.50 vs 116.79±47.29; P=0.017), total corneal astigmatism (51.65±42.75 vs 95.20±57.32; P=0.011), J45 change vector of SICA in the anterior cornea (-0.10±0.18 vs 0.00±0.11; P=0.048) and total cornea surface (-0.14±0.17 vs 0.03±0.12; P=0.001).  Conclusion: The N-CORA decreased significantly after cataract surgery. Superotemporal and temporal incisions caused differences in the meridian components of oblique astigmatism in some patients but did not have a significant effect on the magnitude of corneal astigmatism.</p>","PeriodicalId":50683,"journal":{"name":"Clinical and Investigative Medicine","volume":"45 4","pages":"E16-24"},"PeriodicalIF":0.8,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10609677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Significance of Mannan Binding Lectin-Associated Serine Protease 2 in Urinary Extracellular Vesicles in IgA Nephropathy. 甘露聚糖结合凝集素相关丝氨酸蛋白酶2在IgA肾病尿细胞外囊泡中的意义。
IF 0.8 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2022-09-21 DOI: 10.25011/cim.v45i3.38876
Fan Wu BSc Wu, Yun-Ying Chen, Jian-Xin Huang, Kang-Ying Wang, Hai-Shan Xu, Danhua Lin
PURPOSE Immunoglobulin A (IgA) nephropathy (IgAN) is a common chronic glomerulonephritis and the main cause of end-stage renal diseases. Recent evidence suggests that mannan binding lectin associated serine proteases 2 (MASP2) is related to IgAN; therefore, we investigated the expression and significance of MASP2 in serum and urinary extracellular vesicles (UEVs) in patients with IgAN. METHODS Thirty-eight patients with IgAN and 17 healthy controls were enrolled in this study. UEVs were extracted by ultracentrifugation. The separation by ultra-high-speed centrifuge was verified by transmission electron microscopy (TEM) and nanoparticle tracking analysis (NTA). Candidate internal references (TSG101, CD9, flotillin, β-actin and GAPDH) were identified by western blotting in the control group, and the expression of MASP2 in the UEVs was compared. The levels of MASP2 in the serum and UEVs in the IgAN and control groups were determined by enzyme-linked immunosorbent assay (ELISA). RESULTS TEM and NTA results demonstrated that UEVs were successfully extracted. Western blotting results confirmed that TSG101 was suitable as an internal reference for this study. Compared with the control group, the IgAN group showed positive expression of MASP2. MASP2 levels in the UEVs, determined by ELISA, showed significant differences between IgAN and control groups, which were significantly positively correlated with the level of urinary microalbumin. CONCLUSIONS The level of MASP2 in UEVs was related to IgAN and shows promise as a biomarker for evaluating the severity of renal injury and prognosis of IgAN, thereby helping to elucidate the role of MASP2 in the mannan-binding lectin pathway.
目的:免疫球蛋白A (IgA)肾病(IgAN)是一种常见的慢性肾小球肾炎,是终末期肾脏疾病的主要病因。最近的证据表明甘露聚糖结合凝集素相关丝氨酸蛋白酶2 (MASP2)与IgAN有关;因此,我们研究了MASP2在IgAN患者血清和尿细胞外囊泡(UEVs)中的表达及其意义。方法:38例IgAN患者和17例健康对照者参加本研究。紫外分光光度法提取紫外分光光度。通过透射电子显微镜(TEM)和纳米颗粒跟踪分析(NTA)验证了超高速离心机的分离效果。对照组采用western blotting方法鉴定候选内参(TSG101、CD9、flotillin、β-actin和GAPDH),比较MASP2在UEVs中的表达情况。采用酶联免疫吸附试验(ELISA)检测IgAN组和对照组血清和UEVs中MASP2的水平。结果:TEM和NTA结果表明,UEVs提取成功。Western blotting结果证实TSG101适合作为本研究的内参。与对照组比较,IgAN组MASP2表达阳性。ELISA检测UEVs中MASP2水平在IgAN组与对照组之间存在显著差异,且与尿微量白蛋白水平呈显著正相关。结论:UEVs中MASP2水平与IgAN相关,有望作为评估IgAN肾损伤严重程度和预后的生物标志物,从而有助于阐明MASP2在甘露聚糖结合凝集素途径中的作用。
{"title":"Significance of Mannan Binding Lectin-Associated Serine Protease 2 in Urinary Extracellular Vesicles in IgA Nephropathy.","authors":"Fan Wu BSc Wu,&nbsp;Yun-Ying Chen,&nbsp;Jian-Xin Huang,&nbsp;Kang-Ying Wang,&nbsp;Hai-Shan Xu,&nbsp;Danhua Lin","doi":"10.25011/cim.v45i3.38876","DOIUrl":"https://doi.org/10.25011/cim.v45i3.38876","url":null,"abstract":"PURPOSE Immunoglobulin A (IgA) nephropathy (IgAN) is a common chronic glomerulonephritis and the main cause of end-stage renal diseases. Recent evidence suggests that mannan binding lectin associated serine proteases 2 (MASP2) is related to IgAN; therefore, we investigated the expression and significance of MASP2 in serum and urinary extracellular vesicles (UEVs) in patients with IgAN. METHODS Thirty-eight patients with IgAN and 17 healthy controls were enrolled in this study. UEVs were extracted by ultracentrifugation. The separation by ultra-high-speed centrifuge was verified by transmission electron microscopy (TEM) and nanoparticle tracking analysis (NTA). Candidate internal references (TSG101, CD9, flotillin, β-actin and GAPDH) were identified by western blotting in the control group, and the expression of MASP2 in the UEVs was compared. The levels of MASP2 in the serum and UEVs in the IgAN and control groups were determined by enzyme-linked immunosorbent assay (ELISA). RESULTS TEM and NTA results demonstrated that UEVs were successfully extracted. Western blotting results confirmed that TSG101 was suitable as an internal reference for this study. Compared with the control group, the IgAN group showed positive expression of MASP2. MASP2 levels in the UEVs, determined by ELISA, showed significant differences between IgAN and control groups, which were significantly positively correlated with the level of urinary microalbumin. CONCLUSIONS The level of MASP2 in UEVs was related to IgAN and shows promise as a biomarker for evaluating the severity of renal injury and prognosis of IgAN, thereby helping to elucidate the role of MASP2 in the mannan-binding lectin pathway.","PeriodicalId":50683,"journal":{"name":"Clinical and Investigative Medicine","volume":"45 3","pages":"E47-54"},"PeriodicalIF":0.8,"publicationDate":"2022-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33489720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Clinical and Investigative Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1